Author:
Battalora Linda,Armon Carl,Palella Frank,Li Jun,Overton Edgar T.,Hammer John,Fuhrer Jack,Novak Richard M.,Carlson Kimberly,Spear John R.,Buchacz Kate,
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference41 articles.
1. Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20(17):2165–2174
2. Escota GV, Mondy K, Bush T, Conley L, Brooks JT, Önen N, Patel P, Kojic EM, Henry K, Hammer J, Wood KC, Lichtenstein KA, Overton ET, for the SUN Study Investigators (2016) High prevalence of low bone mineral density and substantial bone loss over 4 years among HIV-infected persons in the era of modern antiretroviral therapy. AIDS Res Hum Retrovir 32(1):59–67
3. Overton ET, Mondy K, Bush TJ (2007) Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN Study [abstract 836]. In: 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA
4. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14(4):F63–F67
5. Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P (2012) Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS 26(7):825–831
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献